Bilirubin And Newborn Jaundice: Understanding The Connection

Jaundice is a common condition in newborns, characterised by a yellow discolouration of the skin and eyes. It is caused by a buildup of bilirubin in the blood, which occurs when a baby's liver is not developed enough to remove it effectively. While mild jaundice is typically harmless and resolves within a couple of weeks, severe cases can lead to serious health complications, including brain damage, if left untreated. Therefore, it is important to understand the amount of bilirubin that can cause jaundice in newborns and the associated risks.

Bilirubin is a yellow substance created when red blood cells break down

Jaundice is a common condition in newborns, characterised by a yellow discolouration of the skin and eyes. It occurs when there is a buildup of bilirubin—a yellow substance and byproduct of broken-down red blood cells—in the blood.

During their lifecycle, red blood cells break down and pass through the bloodstream to the liver, which filters bilirubin with other waste products into bile. This bile, which is coloured yellow by the pigment bilirubin, then exits the body through the intestines.

In newborns, jaundice occurs because their livers are not developed enough to remove bilirubin from the body. This is because a newborn's liver is only about 1% as active as an adult's. As a result, bilirubin builds up in the blood, causing the skin and eyes to appear yellow.

While jaundice usually goes away on its own within a couple of weeks, it can be dangerous if left untreated. In rare cases, severe jaundice can lead to brain damage and other serious health conditions. Therefore, it is important for newborns to be monitored for jaundice and treated if necessary. Treatment options include phototherapy, exchange transfusion, and intravenous immunoglobulin treatment.

A newborn's liver may be immature and unable to remove bilirubin

Jaundice in newborns is a common condition characterised by a yellow discolouration of the skin and eyes. It is caused by a buildup of bilirubin in the baby's blood, which occurs when their liver is not developed enough to remove it effectively. Bilirubin is a yellow substance created when red blood cells break down. While a baby is in the womb, the mother's liver removes bilirubin from the baby's blood via the placenta. However, after birth, the baby's liver must take over this function.

Additionally, some newborns may have underlying disorders or conditions that affect liver function and contribute to jaundice. These include internal bleeding, infections such as sepsis, biliary atresia (blocked or scarred bile ducts), enzyme deficiencies, and abnormalities in red blood cells that cause them to break down rapidly.

Premature babies are also at a higher risk of jaundice as they may not be able to process bilirubin as efficiently as full-term infants. They tend to feed less and have fewer bowel movements, resulting in lower bilirubin elimination through stool. Furthermore, bruising during a difficult birth can lead to higher levels of bilirubin from the breakdown of red blood cells.

Breastfeeding issues can also contribute to jaundice. Insufficient breast milk intake, particularly in the first few weeks, can cause dehydration and reduced urination, leading to bilirubin buildup. Additionally, substances in breast milk can sometimes affect the liver's ability to remove bilirubin, known as breast milk jaundice.

Jaundice in newborns is typically detected by pressing gently on the baby's forehead or nose. If the skin appears yellow where pressure was applied, it indicates mild jaundice. It is important to examine the baby in good lighting conditions, preferably natural daylight.

While jaundice usually resolves on its own within a couple of weeks, severe cases can lead to serious complications such as brain damage if left untreated. Therefore, it is crucial for newborns to be monitored and treated accordingly to prevent potential health risks.

Physiological jaundice is the most common type, affecting 50% of newborns

Jaundice in newborns is the yellowing of an infant's skin and eyes. It occurs when there is a buildup of bilirubin in the baby's blood, which happens because their livers are not yet developed enough to get rid of the bilirubin. Jaundice is a very common condition, affecting up to 60% of full-term babies and 80% of premature babies during their first week of life.

The most common type of jaundice in newborns is physiological jaundice, which affects 50% of newborns. It is a normal condition that develops in most newborns by their second or third day of life. Physiological jaundice is caused by a higher number of red blood cells in newborns compared to adults, which don't live as long, leading to increased bilirubin when they break down. It typically appears between 2 to 4 days after birth and goes away within two weeks as the baby's liver develops and starts to remove excess bilirubin.

Physiological jaundice usually isn't serious and often goes away on its own without treatment. However, it is important for a healthcare provider to check the baby for jaundice, as severe jaundice can lead to brain damage if left untreated. Treatment for jaundice may include phototherapy, where the baby is placed under special blue lights to help their liver get rid of excess bilirubin. In rare cases, an exchange transfusion may be necessary, where some of the baby's blood is replaced with fresh, donated blood.

Other types of jaundice include breastfeeding jaundice, which occurs when a baby doesn't get enough breast milk, and breast milk jaundice, which is caused by substances in the breast milk affecting how the baby's liver breaks down bilirubin. Jaundice can also be caused by underlying diseases or conditions such as internal bleeding, infections, blood type incompatibility between mother and baby, and liver conditions.

Breastfeeding jaundice occurs when a baby doesn't get enough breast milk

Jaundice is a common condition in newborns, characterised by a yellow discolouration of the skin and eyes. It is caused by a buildup of bilirubin in the blood, which occurs when the liver is unable to break it down and pass it from the body.

Breastfeeding jaundice is caused by a combination of factors. Firstly, newborns may not receive an optimal amount of milk, leading to elevated bilirubin levels due to increased reabsorption in the intestines. Inadequate milk intake also delays the passage of meconium, the first tar-like stools. Meconium contains large amounts of bilirubin, which is then transferred back into the infant's circulation.

Additionally, dehydration and low caloric intake associated with insufficient breastfeeding can contribute to the onset of jaundice. Breastfed babies, particularly those with difficulty nursing or getting enough nutrition, are at higher risk. It is important to ensure that the baby is getting enough to eat and is adequately hydrated. Breastfed infants should be fed eight to 12 times a day during their first week of life.

To treat breastfeeding jaundice, it is recommended to increase the frequency of breastfeeding. This can improve the mother's milk supply and the infant's caloric intake and hydration, thereby reducing elevated bilirubin levels. In some cases, supplementation with formula or donor human milk may be necessary.

It is important to closely monitor the baby's bilirubin levels and overall health to ensure that jaundice does not lead to more severe complications, such as brain damage.

Breast milk jaundice is caused by a substance in breast milk that blocks the removal of bilirubin

Jaundice is a common condition in newborns, characterised by a yellowing of the skin and eyes. It occurs when there is a high level of bilirubin in the blood, which can happen when a baby's liver isn't mature enough to remove it from the bloodstream. While jaundice is usually harmless and goes away on its own, severe cases can lead to brain damage if left untreated.

One type of jaundice is breast milk jaundice, which is associated with breastfeeding and typically occurs one week after birth. It is rare, affecting less than 3% of infants, and often goes away on its own without any need to stop breastfeeding. The exact cause of breast milk jaundice is unknown, but it is thought to be linked to a substance in the breast milk that affects how the infant's liver breaks down bilirubin. This substance may prevent certain proteins in the liver from breaking down bilirubin, leading to a build-up in the blood.

Several factors in breast milk have been linked to breast milk jaundice. One factor is an unusual metabolite of progesterone called pregnane-3a,20ß-diol, which is thought to inhibit the conjugation of bilirubin, impeding its excretion. Another factor is the enzyme ß-glucuronidase, which is present in high levels in breast milk and can lead to increased reabsorption of bilirubin instead of its excretion. Interleukin IL1ß, which is also found in breast milk, is thought to have a cholestatic effect that leads to hyperbilirubinemia. Additionally, the epidermal growth factor is present in higher concentrations in breast milk and the serum of infants with breast milk jaundice, which may enhance intestinal resorption of bilirubin.

While the exact cause of breast milk jaundice is still unknown, it is believed to be a combination of genetic and environmental factors. A family history of jaundice in breastfed infants may increase the risk, and it has been found that mutations in the UGT1A1 gene can increase the likelihood of developing breast milk jaundice.

Frequently asked questions